Similar articles

• Effect of amifostine on response rates in locally advanced non-small-cell lung cancer patients treated on randomized controlled trials: a meta-analysis.

  Mell LK, Malik R, Komaki R, Movsas B, Swann RS, Langer C, Antonadou D, Koukourakis M, Mundt AJ. Mell LK, et al. Int J Radiat Oncol Biol Phys. 2007 May 1;68(1):111-8. doi: 10.1016/j.ijrobp.2006.11.043. Epub 2007 Feb 7. Int J Radiat Oncol Biol Phys. 2007. PMID: 17289291 Review.
• Amifostine and radiation therapy: past, present, and future.

  Tannehill SP, Mehta MP. Tannehill SP, et al. Semin Oncol. 1996 Aug;23(4 Suppl 8):69-77. Semin Oncol. 1996. PMID: 8783671 Review.
• Effect of amifostine on survival among patients treated with radiotherapy: a meta-analysis of individual patient data.

  Bourhis J, Blanchard P, Maillard E, Brizel DM, Movsas B, Buentzel J, Langendijk JA, Komaki R, Swan Leong S, Levendag P, Pignon JP. Bourhis J, et al. J Clin Oncol. 2011 Jun 20;29(18):2590-7. doi: 10.1200/JCO.2010.33.1454. Epub 2011 May 16. J Clin Oncol. 2011. PMID: 21576630
• Clinically meaningful differences in patient-reported outcomes with amifostine in combination with chemoradiation for locally advanced non-small-cell lung cancer: an analysis of RTOG 9801.

  Sarna L, Swann S, Langer C, Werner-Wasik M, Nicolaou N, Komaki R, Machtay M, Byhardt R, Wasserman T, Movsas B. Sarna L, et al. Int J Radiat Oncol Biol Phys. 2008 Dec 1;72(5):1378-84. doi: 10.1016/j.ijrobp.2008.03.003. Epub 2008 May 22. Int J Radiat Oncol Biol Phys. 2008. PMID: 18501528
• Administration of the cytoprotectant amifostine.

  Lindemann K. Lindemann K. Clin J Oncol Nurs. 1998 Jul;2(3):101-4. Clin J Oncol Nurs. 1998. PMID: 10232150